Autopsy report · NCT00004227
Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx
Cause of deathNo reason given
Life of this trial
- Registered 9 months after it had already started.
- Ran for about 9 years 1 month before it stopped.
- 32 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- University of Alabama at Birmingham
- Sponsor type
- University, hospital or other
- Conditions
- Head and Neck Cancer
- Interventions
- cetuximab; conventional surgery; radiation therapy
- Participants
- 32
- Sites
- 3
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.